ʻO ka PCR Fluorescence
-
Klebsiella Pneumoniae, Acinetobacter Baumannii a me Pseudomonas Aeruginosa a me Drug Resistance Genes (KPC, NDM, OXA48 a me IMP) Multiplex
Hoʻohana ʻia kēia kit no ka ʻike in vitro qualitative o Klebsiella pneumoniae (KPN), Acinetobacter baumannii (Aba), Pseudomonas aeruginosa (PA) a me ʻehā carbapenem resistance genes (ʻo ia hoʻi me KPC, NDM, OXA48 a me IMP) i nā laʻana sputum kanaka, e hāʻawi i ke kumu o ka mālama ʻana a me ka lāʻau lapaʻau no ka maʻi maʻi maʻi.
-
Mycoplasma Pneumoniae （MP）
Hoʻohana ʻia kēia huahana no ka ʻike in vitro qualitative o Mycoplasma pneumoniae (MP) nucleic acid i loko o ka sputum kanaka a me nā laʻana oropharyngeal swab.
-
Clostridium difficile toxin A/B gene（C.diff）
Hoʻolālā ʻia kēia pahu no ka ʻike in vitro qualitative o clostridium difficile toxin A gene a me toxin B gene i loko o nā laʻana stool mai nā mea maʻi i manaʻo ʻia i ka maʻi clostridium difficile.
-
ʻŌnaehana Kūʻē Carbapenem (KPC/NDM/OXA 48/OXA 23/VIM/IMP)
Hoʻohana ʻia kēia kit no ka ʻike qualitative o nā genes resistance carbapenem i loko o nā ʻano sputum kanaka, rectal swab samples a i ʻole nā kolone maʻemaʻe, me KPC (Klebsiella pneumonia carbapenemase), NDM (New Delhi metallo-β-lactamase 1), OXA48 (oxacillinase 48), OXA23 (oxacillinaseM) (Imipenemase).
-
Influenza A Virus Universal/H1/H3
Hoʻohana ʻia kēia pahu no ka ʻike kūpono o ka maʻi maʻi influenza A ʻano honua, ʻano H1 a me H3 ʻano nucleic acid i loko o nā laʻana swab nasopharyngeal kanaka.
-
ʻO Zaire Ebola Virus
He kūpono kēia pahu no ka ʻike qualitative o Zaire Ebola virus nucleic acid i loko o ka serum a i ʻole plasma samples o nā maʻi i manaʻo ʻia he maʻi Zaire Ebola (ZEBOV).
-
Adenovirus Universal
Hoʻohana ʻia kēia kit no ka ʻike qualitative o ka adenovirus nucleic acid i nā laʻana o ka nasopharyngeal swab a me ka puʻu.
-
4 Nā ʻano o nā maʻi hoʻomake hanu
Hoʻohana ʻia kēia pahu no ka ʻike qualitative o2019-nCoV, ka ma'i influenza A, ka ma'i ma'i influenza B a me ka ma'i ma'i hanu syncytial nucleic acidsi ke kanakaoropharyngeal swab samples.
-
12 Nā ʻano o ka maʻi maʻi hanu
Hoʻohana ʻia kēia kit no ka hui ʻana o ka qualitative detection o SARS-CoV-2, influenza A virus, influenza B virus, adenovirus, mycoplasma pneumoniae, rhinovirus, respiratory syncytial virus a me parainfluenza virus (Ⅰ, II, III, IV) a me metapneumovirus kanaka i loko o nā swabs oropharyngeal..
-
Hepatitis E Virus
He mea kūpono kēia pahu no ka ʻike kūpono o ka maʻi hepatitis E (HEV) nucleic acid i loko o nā laʻana serum a me nā laʻana stool in vitro.
-
Hepatitis A Virus
He kūpono kēia pahu no ka ʻike ʻana i ka maʻi hepatitis A (HAV) nucleic acid i loko o nā laʻana serum a me nā laʻana stool in vitro.
-
ʻO ka Hepatitis B Virus DNA Quantitative Fluorescence
Hoʻohana ʻia kēia pahu no ka ʻike nui ʻana o ka maʻi hepatitis B maʻi nucleic acid i loko o ka serum kanaka a i ʻole ka plasma samples.
